Literature DB >> 29335807

Assessment of in vitro cytotoxic and genotoxic activities of some trimethoprim conjugates.

Devrim Güzel Bayülken1, R Beklem Bostancıoğlu2, A Tansu Koparal2, Berrin Ayaz Tüylü2, Aydan Dağ3, Kadriye Benkli3.   

Abstract

Trimethoprim, a commonly used antibacterial agent, is widely applied in the treatment of variety of infections in human. A few studies have demonstrated an extensive exposure of man to antibiotics, but there is still a lack of data for cytotoxic effects including nephrotoxicity, gastrointestinal toxicity, hematotoxicity, neurotoxicity and ototoxicity. The main purpose behind this study was to determine cytotoxic and genotoxic activities of trimethoprim (1), trimethoprim with maleic acid (2) and trimethoprim in conjugation with oxalic acid dihydrate (3). The cytotoxic effects of these three conjugates were elucidated by employing 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoium bromide (MTT) assay using embryonic rat fibroblast-like cell line (F2408) and H-ras oncogene activated embryonic rat fibroblast-like cancer cell line (5RP7). Additionally, determination of genotoxic activity of these three compounds were studied by using cytokinesis blocked micronucleus assay (CBMN) in human lymphocytes. The results demonstrated that trimethoprim alone and its combination with other compounds are able to induce both cytotoxic and genotoxic damage on cultured cells (F2408, 5RP7, human lymphocytes).

Entities:  

Keywords:  Cytotoxicity; Genotoxicity; Maleic acid; Oxalic acid dihydrate; Trimethoprim

Year:  2018        PMID: 29335807      PMCID: PMC6021285          DOI: 10.1007/s10616-018-0187-7

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  28 in total

Review 1.  Trimethoprim and sulfonamide resistance.

Authors:  P Huovinen; L Sundström; G Swedberg; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

2.  Determination of the activity of pyrimethamine, trimethoprim, sulfonamides, and combinations of pyrimethamine and sulfonamides against Sarcocystis neurona in cell cultures.

Authors:  D S Lindsay; J P Dubey
Journal:  Vet Parasitol       Date:  1999-04-12       Impact factor: 2.738

Review 3.  Trimethoprim-sulfamethoxazole.

Authors:  J D Smilack
Journal:  Mayo Clin Proc       Date:  1999-07       Impact factor: 7.616

4.  Evaluation of cytogenetic and DNA damage induced by the antibacterial drug, trimethoprim.

Authors:  A Abou-Eisha
Journal:  Toxicol In Vitro       Date:  2005-11-28       Impact factor: 3.500

5.  The genotoxicity of diaveridine and trimethoprim.

Authors:  T Ono; T Sekiya; Y Takahashi; Y F Sasaki; F Izumiyama; E Nishidate; S Tsuda; T Ohta
Journal:  Environ Toxicol Pharmacol       Date:  1997-09       Impact factor: 4.860

6.  Design, Synthesis, and Biological Evaluation of Coupled Bioactive Scaffolds as Potential Anticancer Agents for Dual Targeting of Dihydrofolate Reductase and Thioredoxin Reductase.

Authors:  Hui-Li Ng; Xiang Ma; Eng-Hui Chew; Wai-Keung Chui
Journal:  J Med Chem       Date:  2017-02-24       Impact factor: 7.446

Review 7.  The HUman MicroNucleus Project--An international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans.

Authors:  M Fenech; N Holland; W P Chang; E Zeiger; S Bonassi
Journal:  Mutat Res       Date:  1999-07-16       Impact factor: 2.433

8.  The toxicity of sulfamethazine to Daphnia magna and its additivity to other veterinary sulfonamides and trimethoprim.

Authors:  Marco De Liguoro; Barbara Fioretto; Carlo Poltronieri; Guglielmo Gallina
Journal:  Chemosphere       Date:  2009-03-09       Impact factor: 7.086

Review 9.  Mutagen sensitivity assays in population studies.

Authors:  William W Au
Journal:  Mutat Res       Date:  2003-11       Impact factor: 2.433

Review 10.  Drug Development Against Metastatic Cancers.

Authors:  Chen Wang; Sui Huang
Journal:  Yale J Biol Med       Date:  2017-03-29
View more
  1 in total

1.  A drug-tunable Flt23k gene therapy for controlled intervention in retinal neovascularization.

Authors:  Jingxiang Zhong; Guei-Sheung Liu; Jinying Chen; Fan-Li Lin; Jacqueline Y K Leung; Leilei Tu; Jiang-Hui Wang; Yu-Fan Chuang; Fan Li; Hsin-Hui Shen; Gregory J Dusting; Vickie H Y Wong; Leszek Lisowski; Alex W Hewitt; Bang V Bui
Journal:  Angiogenesis       Date:  2020-09-15       Impact factor: 10.658

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.